Volume 14, Issue 7, Pages (February 2016)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 2, Pages (August 2014)
Advertisements

M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 35, Issue 4, Pages (August 2009)
Volume 124, Issue 6, Pages (March 2006)
Volume 140, Issue 2, Pages (February 2011)
Volume 145, Issue 6, Pages e1 (December 2013)
Volume 8, Issue 1, Pages (July 2014)
Volume 16, Issue 2, Pages (August 2014)
Substance P Enhances the Production of Interferon-induced Protein of 10 kDa by Human Keratinocytes in Synergy with Interferon-γ  Naoko Kanda, Shinichi.
Volume 6, Issue 6, Pages (March 2014)
Volume 24, Issue 7, Pages (July 2016)
Joan Ritho, Stefan T. Arold, Edward T.H. Yeh  Cell Reports 
Volume 33, Issue 2, Pages (January 2009)
Volume 11, Issue 6, Pages (June 2012)
Volume 16, Issue 6, Pages (December 2004)
Volume 23, Issue 12, Pages e6 (June 2018)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Volume 15, Issue 9, Pages (May 2016)
Volume 23, Issue 5, Pages (May 2018)
Volume 20, Issue 7, Pages (August 2017)
Volume 18, Issue 8, Pages (August 2010)
Volume 16, Issue 1, Pages (July 2014)
Volume 3, Issue 5, Pages (May 2013)
Volume 23, Issue 3, Pages (February 2013)
Volume 10, Issue 3, Pages (September 2011)
Crystal Structure of Tetrameric Arabidopsis MYC2 Reveals the Mechanism of Enhanced Interaction with DNA  Teng-fei Lian, Yong-ping Xu, Lan-fen Li, Xiao-Dong.
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 24, Issue 11, Pages e3 (September 2018)
Volume 16, Issue 8, Pages (August 2016)
Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms  Markus Meissner, Andreas Pinter,
Volume 11, Issue 3, Pages (April 2015)
Volume 117, Issue 5, Pages (November 1999)
Volume 128, Issue 3, Pages (February 2007)
Volume 12, Issue 1, Pages (July 2015)
Volume 6, Issue 6, Pages (March 2014)
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Volume 19, Issue 12, Pages (December 2011)
Volume 12, Issue 9, Pages (September 2015)
Volume 9, Issue 5, Pages (November 2017)
Jiao Yang, Melesse Nune, Yinong Zong, Lei Zhou, Qinglian Liu  Structure 
Volume 39, Issue 3, Pages (August 2010)
Volume 13, Issue 4, Pages (October 2015)
Volume 12, Issue 2, Pages (August 2012)
Melissa L. Ehlers, Barbara Celona, Brian L. Black  Cell Reports 
Volume 16, Issue 12, Pages (September 2016)
Volume 16, Issue 3, Pages (September 2014)
Volume 18, Issue 6, Pages (December 2015)
Volume 96, Issue 3, Pages (February 1999)
Volume 9, Issue 4, Pages (April 2011)
Volume 21, Issue 4, Pages (October 2017)
Volume 20, Issue 5, Pages (November 2016)
Volume 24, Issue 4, Pages e6 (July 2018)
Flora Ambre Honoré, Vincent Méjean, Olivier Genest  Cell Reports 
Volume 21, Issue 6, Pages (November 2017)
Volume 12, Issue 1, Pages (July 2015)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 20, Issue 10, Pages (September 2017)
Structural Insight into BLM Recognition by TopBP1
Volume 24, Issue 6, Pages (June 2016)
Volume 68, Issue 2, Pages e4 (October 2017)
The Innate Immune Sensor LGP2 Activates Antiviral Signaling by Regulating MDA5- RNA Interaction and Filament Assembly  Annie M. Bruns, George P. Leser,
Volume 23, Issue 7, Pages (July 2015)
Volume 37, Issue 2, Pages (January 2010)
Volume 6, Issue 3, Pages (February 2014)
Volume 14, Issue 1, Pages (July 2013)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Volume 69, Issue 1, Pages e6 (January 2018)
Volume 11, Issue 6, Pages (June 2012)
Presentation transcript:

Volume 14, Issue 7, Pages 1632-1640 (February 2016) Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins  Megan R. Edwards, Gai Liu, Chad E. Mire, Suhas Sureshchandra, Priya Luthra, Benjamin Yen, Reed S. Shabman, Daisy W. Leung, Ilhem Messaoudi, Thomas W. Geisbert, Gaya K. Amarasinghe, Christopher F. Basler  Cell Reports  Volume 14, Issue 7, Pages 1632-1640 (February 2016) DOI: 10.1016/j.celrep.2016.01.049 Copyright © 2016 The Authors Terms and Conditions

Cell Reports 2016 14, 1632-1640DOI: (10.1016/j.celrep.2016.01.049) Copyright © 2016 The Authors Terms and Conditions

Figure 1 EBOV and MARV Show Differential Expression of IFN-Regulated Genes (A–C) THP-1 cells were either mock-infected or infected with EBOV or MARV-Ang at an MOI of three. (A) RNA from infected THP-1 cells was subjected to expression analysis by mRNA deep sequencing (mRNA-seq). The heatmap displays the expression profile of IFN response genes at 6, 12, and 24 hpi. The expression levels have been normalized to account for varying library sizes. These have been scaled and centered, with green indicating a larger number of transcripts and red indicating a fewer number of transcripts. (B) Filoviral VP35 and NP mRNA expression levels represented in terms of transcript counts. (C) Expression levels of 6 ISGs from EBOV and MARV-Ang infected cells were analyzed by qRT-PCR at 6, 12, and 24 hpi. The values were normalized to RPS11. The y axis scale for CXCL10 and MX1 is log10. The y axis scale for IFIT2, IDO1, IFITM1, and BST2 is linear. Cell Reports 2016 14, 1632-1640DOI: (10.1016/j.celrep.2016.01.049) Copyright © 2016 The Authors Terms and Conditions

Figure 2 eVP35 and mVP35 Inhibit Virus-Induced IFN-β Production with Different Efficiencies (A) An IFN-β luciferase reporter assay in the presence of empty vector (pCAGGS) or increasing concentrations of eVP35, mVP35, or aVP35 (2.5, 25, and 250 ng). At 24 hr post-transfection, cells were infected with SeV, and IFN-β activity was assessed by measuring luciferase activity 18 hr later. The VP35 expression was assessed by western blot for FLAG (right). (B) An IFN bioassay in the presence of empty plasmid (pCAGGS), eVP35, or mVP35. The transfected cells were infected with SeV to activate RIG-I signaling. The supernatants were harvested 18 hpi and UV inactivated. The serial 5-fold dilutions of the supernatant were used to overlay Vero cells. At 24 hr later, Vero cells were infected with NDV-GFP (MOI = 1), and the percent of infected cells was determined 18 hr later by monitoring GFP. The GFP signal obtained for Vero cells untreated by supernatants and infected with NDV-GFP was set at 100%; all other conditions were normalized to this control. The results from 1:625 dilution of supernatants are shown. (C) Schematic of chimeric and truncated VP35 constructs. The filovirus VP35 proteins contain an N-terminal nucleoprotein binding peptide (NPBP) followed by an oligomerization domain and a C-terminal dsRNA-binding domain termed the IID. The chimeric VP35s were designed by swapping the C terminus of EBOV (gray) and MARV (black). (D) Same assay protocol as (A), but transfected with wild-type eVP35, wild-type mVP35, chimeric VP35, or N- or C-terminal VP35s. The protein expression for the controls and the samples receiving the highest concentration of VP35 constructs was assessed by western blot for FLAG (right). (A, B, and D) Values represent the mean and SEM of triplicate samples, and statistical significance was assessed by a one-way ANOVA comparing columns as indicated: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001. Cell Reports 2016 14, 1632-1640DOI: (10.1016/j.celrep.2016.01.049) Copyright © 2016 The Authors Terms and Conditions

Figure 3 eVP35 IID and mVP35 IID Have Different Interaction Modes and Binding Affinities for dsRNA (A) The two types of interactions are highlighted in the cartoon representation of the asymmetric unit of Protein Data Bank (PDB): 3L25. The eVP35 IID recognizes both the blunt ends (red molecule) and double stranded backbone of dsRNA (yellow molecule). The symmetry related eVP35 IID molecules are colored gray. (B) mVP35 IID interacts with the backbone of dsRNA. Shown are the mVP35 IID molecules in the crystal structure (PDB: 4GHL). One mVP35 IID molecule is colored blue, and the symmetry mates are shown in gray. (C) Dot blot assay shows that eVP35 IID (red) has a higher affinity for 25 bp than mVP35 IID (blue). 0 to 250 μM of IID was incubated with 5 nM of P32-25 bp dsRNA. The fraction bound of dsRNA was normalized and plotted against protein concentration (μM). The error bars in the figure represent SD. (D) Sequences of mVP35 IID and eVP35 IID are aligned using ClustalW. The fully conserved residues are colored blue and labeled with an asterisk (∗); the strongly conserved are colored green and labeled with a colon (:); and the weakly conserved are colored navy and labeled with a period (.). The residues, R305, K309, and K319, are highlighted. Cell Reports 2016 14, 1632-1640DOI: (10.1016/j.celrep.2016.01.049) Copyright © 2016 The Authors Terms and Conditions

Figure 4 Differential Inhibition of RLR Activity by eVP35 IID and mVP35 IID (A–C) Three residues in the CBP of eVP35 IID were selected for mutational analysis. The color scheme is the same as in Figure 3. The residues (A) R305, (B) K309, and (C) K319 are shown in stick representation. The hydrogen bonding is shown as blue dotted lines. (D) Dissociation constants (KD) are calculated from the dot blot assay data for VP35 IID (wild-type and mutants) and 25 bp dsRNA. (E and F) ATPase assays were used to test inhibitory effects of eVP35 IID wild-type, eVP35 IID mutants, and mVP35 IID. The RIG-I (1 μM) was activated by (E) 10 ng of 25 bp dsRNA or (F) 50 ng of LMW poly(I:C) in the presence and absence of IID at 25 μM. The statistical significance is as indicated: not significant: n.s., ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Cell Reports 2016 14, 1632-1640DOI: (10.1016/j.celrep.2016.01.049) Copyright © 2016 The Authors Terms and Conditions